newsfilter
← Latest News
GlobeNewswire·

BioAtla to Announce Second Quarter 2024 Financial Results and Provide Business Highlights on August 8, 2024

SAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- BioAtla, Inc. (NASDAQ:BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the